SlowBull
The Business Brief MONDAY, 31 AUGUST 2026
← All stories
Markets

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

1 source ·1 article ·1h ago

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.

Covered by 1 outlet

Nytimes 1

All coverage · 1 article

NYT Business ·1h ago

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.